Trade Summary

1 week ago, Knight Jeff E., serving as COO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 9,911 shares at $37.37 per share, for a total transaction value of $370,411.00. Following this transaction, Knight Jeff E. now holds 112,018 shares of CRNX.

This sale represents a 8.00% decrease in Knight Jeff E.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 2 days after the trade was made.

Crinetics Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.